View recent presentations and learn more about upcoming events.
Sep 26, 2019
London, UK
Oct 22, 2019
Basel, Switzerland
Nov 20, 2019
London, UK
Dec 05, 2019
London, UK
Sep 18, 2019
London, UK
Sep 05-06, 2019
Zurich, Switzerland
July 18, 2019
Basel, Switzerland
Jun 20, 2019
London, UK
Jun 19, 2019
London, UK
Jun 05, 2019
New York, USA
Jun 05, 2019
Interlaken, Switzerland
Jun 04, 2019
New York, USA
Jun 02, 2019
Chicago, USA
May 29, 2019
New York, USA
May 23, 2019
Boston, USA
May 08, 2019
Philadelphia, USA
Apr 24, 2019
Mar 27, 2019
Basel, Switzerland
Mar 22, 2019
Mar 21, 2019
Zurich, Switzerland
Mar 18, 2019
New York, USA
Mar 12, 2019
Miami, USA
Mar 11, 2019
Boston, USA
Mar 06, 2019
London, UK
Mar 01, 2019
New York, USA
Feb 28, 2019
Basel, Switzerland
Feb 19, 2019
New York, USA
Feb 14, 2019
New York, USA
Jan 30, 2019
Basel, Switzerland
Jan 07, 2019
San Francisco, USA
Dec 05, 2018
New York, USA
Dec 05, 2018
London, UK
Dec 04, 2018
London, UK
Nov 27, 2018
New York, USA
Nov 14, 2018
London, UK
Nov 13, 2018
London, UK
Nov 13, 2018
Paris, France
Nov 12-13, 2018
Phoenix, USA
Nov 12, 2018
Frankfurt, Germany
Nov 07-08, 2018
Chicago, USA
Nov 07, 2018
Sep 26, 2018
London, UK
Sep 17, 2018
Basel, Switzerland
Download the presentation (PDF 2.5 MB)
Sep 13, 2018
London, UK
Sep 12-13, 2018
New York, USA
Sep 06-07, 2018
Zurich, Switzerland
Sep 05, 2018
Boston, USA
Jul 18, 2018
Basel, Switzerland
Interim financial report (PDF 0.5 MB)
Jun 29, 2018
Download the presentation (PDF 1.2 MB)
Download the podcast (MP3 17 MB)
Read the media release:
Jun 21, 2018
London, UK
Jun 20, 2018
London, UK
Jun 13-15, 2018
Sonoma, USA
Jun 13, 2018
London, UK
Jun 11-12, 2018
Los Angeles, USA
Jun 06, 2018
New York, USA
Jun 05-06, 2018
Interlaken, Switzerland
Jun 03, 2018
Chicago, USA
May 31, 2018
New York, USA
May 22, 2018
May 21, 2018
New York, USA
May 18, 2018
Visit the Amgen website
Novartis and Amgen jointly promote Aimovig™ in the US
Apr 09, 2018
08:00 CEST – Investor call 1
18:00 CEST – Investor call 2
Download the presentation (PDF 0.6 MB)
Apr 03, 2018
Mar 23, 2018
Zurich, Switzerland
Mar 21, 2018
New York, USA
Mar 14, 2018
Miami, USA
Mar 12-13, 2018
Boston, USA
Mar 02, 2018
Basel, Switzerland
Feb 27, 2018
Snowbird, USA
Feb 27, 2018
London, UK
Feb 15, 2018
New York, USA
Jan 24, 2018
Basel, Switzerland
Condensed financial report (PDF 0.5 MB)
Jan 08, 2018
San Francisco, USA
Paul Hudson
Chief Executive Officer of Novartis Pharmaceuticals
Dec 11, 2017
Basel, Switzerland
Download the presentation (PDF 1.9 MB)
Download the podcast (MP3 25 MB)
Read the media releases:
Dec 07, 2017
New York, USA
Dec 07, 2017
London, UK
Nov 30, 2017
Paris, France
Nov 30, 2017
London, UK
Nov 15, 2017
London, UK
Nov 14, 2017
London, UK
Nov 07, 2017
Scottsdale, USA
Nov 07, 2017
Paris, France
Oct 24, 2017
Basel, Switzerland
Interim financial report (PDF 0.5 MB)
Sep 28, 2017
London, UK
Sep 19, 2017
Munich, Germany
Sep 18, 2017
Basel, Switzerland
Audio webcast on the topic of Novartis approach to Corporate Responsibility, including Environmental, Social and Governance issues (ESG)
Juergen Brokatzky-Geiger
Global Head of Corporate Responsibility
Vas Narasimhan
Global Head of Drug Development & Chief Medical Officer for Novartis
Shannon Klinger
Chief Ethics & Compliance Officer and Head Litigation
Sep 14, 2017
London, UK
Sep 14, 2017
Ermatingen, Switzerland
Sep 11, 2017
New York, USA
Sep 06, 2017
Boston, USA
Aug 27, 2017
Barcelona, Spain
Jul 18, 2017
Basel, Switzerland
Interim financial report (PDF 0.5 MB)
Jun 22, 2017
London, UK
Jun 21, 2017
London, UK
Jun 16, 2017
Basel, Switzerland
Jun 15-16, 2017
Sonoma, USA
Jun 13-14, 2017
Rancho Palos Verdes, USA
Jun 08, 2017
Zurich, Switzerland
Jun 07, 2017
New York, USA
May 30-31, 2017
Boston, USA
Download the presentations:
Novartis Group (PDF 1.5 MB)
Pharmaceuticals (PDF 1.8 MB)
Oncology (PDF 1.6 MB)
NIBR (PDF 3.2 MB)
Sandoz (PDF 1.9 MB)
Alcon (PDF 1.5 MB)
Development (PDF 2.3 MB)
May 17-18, 2017
Las Vegas, USA
May 03, 2017
Boston, USA
Apr 25, 2017
Basel, Switzerland
Interim financial report (PDF 0.5 MB)
Mar 28, 2017
Paris, France
Mar 14, 2017
Miami, USA
Mar 13, 2017
Paris, France
Mar 07, 2017
Boston, USA
Mar 01, 2017
London, UK
Feb 15, 2017
New York, USA
Feb 13, 2017
Orlando, USA
Jan 25, 2017
Basel, Switzerland
Jan 09, 2017
San Francisco, USA
Joseph Jimenez
Chief Executive Officer of Novartis
Dec 07, 2016
New York, USA
Dec 07, 2016
London, UK
Dec 01, 2016
London, UK
Nov 30, 2016
Paris, France
Nov 28-29, 2016
New York, USA
Nov 16, 2016
London, UK
Nov 15-16, 2016
New York, USA
Nov 15, 2016
London, UK
Nov 14, 2016
New York, USA
Nov 14, 2016
Paris, France
Nov 06-08, 2016
Phoenix, USA
Oct 25, 2016
Basel, Switzerland
Interim financial report (PDF 0.5 MB)
Download the presentation (PDF 1.1 MB)
Download the podcast (PDF 9.5 MB)
Sep 22, 2016
London, UK
Sep 16, 2016
Basel, Switzerland
Audio webcast on the topic of Novartis approach to Corporate Responsibility, including Environmental, Social and Governance issues (ESG)
Jürgen Brokatzky-Geiger
Global Head Corporate Responsibility
Shannon Klinger
Chief Ethics and Compliance Officer and Head Litigation
Disclaimer: The information in the presentations on these pages was factually accurate on the date of publication. These presentations remain on the Novartis website for historical purposes only. Novartis assumes no responsibility to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.
Investors International:
Call +41 61 324 79 44
Investors North America:
Call +1 862 778 3275
Novartis Share Registry:
For information relating to the registration of your shares, including name or address changes, please contact us by e‑mail or telephone:
Call +41 61 324 72 04
This site is intended for a global audience.
